Details
Stereochemistry | ACHIRAL |
Molecular Formula | C36H60O2 |
Molecular Weight | 524.8604 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 4 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C
InChI
InChIKey=VYGQUTWHTHXGQB-FFHKNEKCSA-N
InChI=1S/C36H60O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-25-35(37)38-30-28-32(3)23-20-22-31(2)26-27-34-33(4)24-21-29-36(34,5)6/h20,22-23,26-28H,7-19,21,24-25,29-30H2,1-6H3/b23-20+,27-26+,31-22+,32-28+
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/8801161
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/8801161
Retonol, also known as Vitamin A1, is a vitamin found in food and used as a dietary supplement. It is used to treat and prevent vitamin A deficiency. It is also used to prevent further issues in those who have measles. Retinol is used as a metabolic precursor of retinoic acid to treat skin-related conditions, such as cellulite, skin aging, photodamage.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2354 Sources: https://www.ncbi.nlm.nih.gov/pubmed/30972178 |
|||
Target ID: O95237 Gene ID: 9227.0 Gene Symbol: LRAT Target Organism: Homo sapiens (Human) |
|||
Target ID: Q96NR8 Gene ID: 145226.0 Gene Symbol: RDH12 Target Organism: Homo sapiens (Human) Sources: https://www.drugbank.ca/drugs/DB00162 |
|||
Target ID: Q92781 Gene ID: 5959.0 Gene Symbol: RDH5 Target Organism: Homo sapiens (Human) Sources: https://www.drugbank.ca/drugs/DB00162 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Unknown Approved UseUnknown |
|||
Preventing | Unknown Approved UseUnknown |
|||
Preventing | Unknown Approved UseUnknown |
|||
Primary | AQUASOL A Approved UseUsed to treat and prevent symptoms of vitamin A deficiency such as xerophthalmia and night blindness. Used as a dietary supplement to prevent vitamin A deficiency in patients with GI diseases (e.g., malabsorption syndromes) and those with abnormal storage and transport of vitamin A (e.g., abetalipoproteinemia, protein deficiency, diabetes mellitus, hyperthyroidism, fever, liver disease, cystic fibrosis with hepatic involvement). Launch Date1949 |
|||
Palliative | AQUASOL A Approved UseChildren with severe measles have been found to have low serum concentrations of vitamin A; WHO and AAP recommend that vitamin A supplements be given to all children with acute measles, regardless of their country of residence. Launch Date1949 |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[Review of acute hydrocephalus caused by administration of vitamin A in massive doses in nursing infants; based on 100 cases]. | 1957 Feb |
|
Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide. | 1976 Jul |
|
Bilateral transverse sinus obstruction in benign intracranial hypertension due to hypervitaminosis A. | 1978 Aug |
|
McCollum Award Lecture, 1992: vitamin A absorption, transport, cellular uptake, and storage. | 1992 Oct |
|
Hepatic hyper-vitaminosis A: importance of retinyl ester level determination. | 2000 Mar |
|
Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease. | 2000 Oct |
|
Effects of excess vitamin A on development of cranial neural crest-derived structures: a neonatal and embryologic study. | 2000 Oct |
|
[Hypercalcemia due to chronic vitamin A use by an elderly patient with renal insufficiency]. | 2001 Jan 13 |
|
Use of vitamin supplements and cataract: the Blue Mountains Eye Study. | 2001 Jul |
|
Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. | 2001 Nov |
|
Restoring effects of vitamin A on surfactant synthesis in nitrofen-induced congenital diaphragmatic hernia in rats. | 2001 Sep 15 |
|
The anemia of vitamin A deficiency: epidemiology and pathogenesis. | 2002 Apr |
|
Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats. | 2003 Apr |
|
PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation. | 2003 Feb |
|
Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia. | 2003 May |
|
Vitamin A deficiency and relational memory deficit in adult mice: relationships with changes in brain retinoid signalling. | 2003 Oct 17 |
|
Vitamin A prevents high fat diet-induced ACF development and modifies the pattern of expression of peroxisome proliferator and retinoic acid receptor m-RNA. | 2004 |
|
Modulation of resistin expression by retinoic acid and vitamin A status. | 2004 Apr |
|
Vitamin A regulates proliferation and apoptosis of human T- and B-cells. | 2004 Dec |
|
A palmitoylation switch mechanism in the regulation of the visual cycle. | 2004 Jun 11 |
|
Age differences in vitamin A intake among Canadian Inuit. | 2004 Nov-Dec |
|
Differential effects of vitamin A on fetal lung growth and diaphragmatic formation in nitrofen-induced rat model. | 2005 |
|
Brain tissue fragments in the amniotic fluid of rats with neural tube defect. | 2005 Apr |
|
beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells. | 2005 Aug 15 |
|
Effect of vitamin A content in cafeteria diet on the expression of nuclear receptors in rat subcutaneous adipose tissue. | 2005 Jun |
|
Vitamin a deficiency and anaemia in young children living in a malaria endemic district of western Kenya. | 2005 Jun |
|
Vitamin A deficiency induces prooxidant environment and inflammation in rat aorta. | 2005 Jun |
|
Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. | 2005 Jun 14 |
|
Extra-hepatic vitamin A concentrations in captive Rhesus (Macaca mulatta) and Marmoset (Callithrix jacchus) monkeys fed excess vitamin A. | 2005 Mar |
|
Megalin-mediated reuptake of retinol in the kidneys of mice is essential for vitamin A homeostasis. | 2005 Nov |
|
Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism. | 2005 Nov 1 |
|
Development of a versatile reporter assay for studies of retinol uptake and metabolism in vivo. | 2005 Nov 1 |
|
Retinoid metabolism during development of liver cirrhosis. | 2005 Nov 15 |
|
Vitamin A supplementation induces adipose tissue loss through apoptosis in lean but not in obese rats of the WNIN/Ob strain. | 2005 Oct |
|
Acyl coenzyme A dependent retinol esterification by acyl coenzyme A: diacylglycerol acyltransferase 1. | 2005 Oct 15 |
|
Retinol induces permeability transition and cytochrome c release from rat liver mitochondria. | 2005 Oct 30 |
|
Expression of keratinocyte transglutaminase in cornea of vitamin A-deficient rats. | 2005 Sep |
|
Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle. | 2005 Sep 20 |
|
Transmembrane protein GDE2 induces motor neuron differentiation in vivo. | 2005 Sep 30 |
|
Effects of nitrofen and vitamins A, C and E on maturation of cultured human H441 pneumocytes. | 2006 |
|
Vitamin A improves Pax3 expression that is decreased in the heart of rats with experimental diaphragmatic hernia. | 2006 Feb |
|
Comparative ligand-binding analysis of ten human lipocalins. | 2006 Feb |
|
Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells. | 2006 Feb |
|
Expression of Connexin 43 in the hearts of rat embryos exposed to nitrofen and effects of vitamin A on it. | 2006 Jan |
|
Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis. | 2006 Jan |
|
Hypervitaminosis A-induced liver fibrosis: stellate cell activation and daily dose consumption. | 2006 Mar |
Patents
Sample Use Guides
The role of vitamin A (2.72 μM/7 ml culture), a naturally occurring antioxidant upon arsenic-induced genotoxicity; with respect to chromosomal aberrations (structural and numerical) and micronuclei. Whole blood cultures set for 72 h were exposed to test chemicals for a period of 24 h ahead of harvesting. Arsenic concentrations tested in the present study are 0.36, 0.72 and 1.4 μM/7 ml culture. Mitomycin C (MMC), the direct acting mutagen was used as positive control.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
525116
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
NCI_THESAURUS |
C804
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
FDA ORPHAN DRUG |
295109
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
FDA ORPHAN DRUG |
805420
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
LOINC |
38496-6
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
FDA ORPHAN DRUG |
583417
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
FDA ORPHAN DRUG |
483315
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
DSLD |
2624 (Number of products:460)
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
DSLD |
2782 (Number of products:618)
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
RETINYL PALMITATE
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
1D1K0N0VVC
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
DBSALT000855
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
CHEMBL1675
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
5280531
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
CHEMBL986
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
C1217
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
35406
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | RxNorm | ||
|
79-81-2
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
m11481
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | Merck Index | ||
|
758478
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
1D1K0N0VVC
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
VITAMIN A PALMITATE
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | Description: A yellow to brownish yellow, oily liquid. Solubility: Practically insoluble in water; soluble or partly soluble in dehydrated ethanol R; miscible with organic solvents. Category: Vitamin. Storage: The oily form of Retinol concentrate should be kept in a well-closed and well-filled container, protected from light. Once the container has been opened its contents should be used as soon as possible; any part of the contents not used at once should be protected by an atmosphere of inert gas. Labelling: The designation on the container should state the name of the retinol ester or esters, and their quantities expressed asthe content of vitamin A in International Units (IU) per gram, whether any stabilizing agents are added and their quantities, as wellas the method of restoring the solution if partial crystallization has occurred.Additional information: Even in the absence of light the oily form of Retinol concentrate is gradually degraded on exposure to ahumid atmosphere, the decomposition being faster at higher temperatures. Partial crystallization may occur in concentrated solutions and upon refrigeration. | ||
|
DTXSID1021241
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
17616
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
4197
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
201-228-5
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
1602502
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
100000091269
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
C014794
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
SUB04225MIG
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD